Scientific statement on obesity

Endocrine Society issues statement on causes of obesity, highlights biological process governing weight stability, calls for more research on factors influencing obesity such as endocrine disruptors

Children significantly exposed to EDCs and neurotoxins

Danish EPA assesses risk of young and unborn children’s exposure to endocrine disruptors and neurotoxins; phthalates, bisphenol A, and lead identified among most critical substances

Restriction of 4 phthalates progressing

ECHA’s Committee for Socio-Economic Analysis issues final opinion in favor of banning endocrine disrupting phthalates DEHP, DBP, DIBP, and BBP in consumer articles; all 4 phthalates relevant for food contact materials

Next meeting on EDC criteria scheduled

EU Member States to discuss and possibly vote on Commission’s draft criteria to identify endocrine disruptors on July 4, 2017

Endocrine experts concerned about EU EDC criteria

Endocrinology societies send letter to EU Commission, urge Member States to work on EDC criteria that better protect the environment and human health

Vote on EDC criteria on hold

EU Commission presents latest revised draft of criteria to identify endocrine disruptors to Member States; no formal vote taken; next meeting not yet scheduled

In vitro testing of paper and board FCMs

Scientists test paper and board FCMs in 8 in vitro bioassays; all 20 samples showed positive responses in at least one of the assays; chemicals in paper and board FCMs require further investigation to ensure safety

New test methods for EDCs needed

JRC expert survey identifies gaps in test methods for evaluating endocrine disruptors; new methods for thyroid, metabolic, immune disorders, as well as hormone-related cancers seen as priority

EDC criteria vote postponed

EU Commission delays vote on draft criteria for identification of endocrine disrupting chemicals, scheduled to be held at the latest meeting of the Standing Committee on Plants, Animals, Food and Feed

Case study on different sets of EDC criteria

Industry-sponsored study assesses four natural substances using EU Commission’s different options for criteria to identify endocrine disruptors; highlights need for including potency considerations in EDC criteria